SUPERSTRING CAPITAL MANAGEMENT LP: 13F holdings
CIK 19311182026Q2
| Positions | 32 |
|---|
| Reported value | $158.4m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 32 (-3 vs prior quarter) |
|---|
| Reported value | $158.4m (+13.2%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| COGT COGENT BIOSCIENCES INC | 343,284 | $13.3m | 8.4% |
| AXSM AXSOME THERAPEUTICS INC. | 53,916 | $13.2m | 8.3% |
| GMAB GENMAB A/S | 430,600 | $11.8m | 7.5% |
| CLDX CELLDEX THERAPEUTICS INC NEW | 287,583 | $10.7m | 6.8% |
| TRVI TREVI THERAPEUTICS INC | 524,224 | $9.8m | 6.2% |
| RVMD REVOLUTION MEDICINES INC | 51,053 | $9.6m | 6.0% |
| DFTX DEFINIUM THERAPEUTICS INC | 188,282 | $8.9m | 5.6% |
| VIR VIR BIOTECHNOLOGY INC | 853,685 | $8.7m | 5.5% |
| IMVT IMMUNOVANT INC | 208,368 | $8.0m | 5.1% |
| UROGEN PHARMA LTD | 191,313 | $7.0m | 4.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1931118")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples